Free Trial

Squarepoint Ops LLC Sells 126,390 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA logo with Medical background

Squarepoint Ops LLC reduced its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 88.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 15,730 shares of the medical instruments supplier's stock after selling 126,390 shares during the quarter. Squarepoint Ops LLC's holdings in DENTSPLY SIRONA were worth $299,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Nuance Investments LLC grew its stake in shares of DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after acquiring an additional 2,708,097 shares during the period. Norges Bank bought a new stake in shares of DENTSPLY SIRONA in the fourth quarter worth approximately $45,730,000. AQR Capital Management LLC grew its stake in shares of DENTSPLY SIRONA by 245.1% in the fourth quarter. AQR Capital Management LLC now owns 2,893,023 shares of the medical instruments supplier's stock worth $54,389,000 after acquiring an additional 2,054,767 shares during the period. Price T Rowe Associates Inc. MD grew its stake in shares of DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock worth $238,186,000 after acquiring an additional 1,975,404 shares during the period. Finally, Cooke & Bieler LP grew its stake in shares of DENTSPLY SIRONA by 24.3% in the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock worth $174,101,000 after acquiring an additional 1,794,391 shares during the period. 95.70% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently issued reports on XRAY. UBS Group dropped their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Mizuho lowered their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Thursday, March 13th. Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Wells Fargo & Company lowered their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Finally, Piper Sandler lowered their price target on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. Eleven equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA currently has an average rating of "Hold" and an average price target of $20.36.

Get Our Latest Stock Analysis on DENTSPLY SIRONA

DENTSPLY SIRONA Trading Up 0.3%

XRAY stock opened at $15.94 on Friday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $27.95. The stock has a market capitalization of $3.18 billion, a price-to-earnings ratio of -7.70, a price-to-earnings-growth ratio of 1.80 and a beta of 0.95. The firm's fifty day simple moving average is $14.60 and its two-hundred day simple moving average is $16.96.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business had revenue of $879.00 million for the quarter, compared to analysts' expectations of $854.75 million. During the same quarter in the previous year, the business posted $0.42 earnings per share. The business's revenue was down 7.8% compared to the same quarter last year. As a group, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.02%. The ex-dividend date is Friday, June 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is -14.10%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines